What if you invested $1,000 in Pfizer in 2010? (Inflation-Adjusted)
PFE · Healthcare · Adjusted to 2026 dollars using BLS CPI-U data
View nominal (non-adjusted) versionPfizer turned $1,000 into $3,281 between 2010 and today. Impressive on paper, but inflation over that span came to 53% (BLS CPI-U). Adjusted for that erosion in purchasing power, your real gain in constant 2010 dollars is $2,144, which works out to a +4.6% annualized real growth rate over 17 years.
Nominal final value
$3,281
+228.1% total return
Real value (2010 dollars)
$2,144
+114.4% real total return
Real annualized return
+4.6%
vs. +7.4% nominal annualized
Year-by-Year (Inflation-Adjusted)
$1,000 in Pfizer since 2010, values in constant 2010 dollars
| Year | Nominal Value | Real Value (2010 $) |
|---|---|---|
| 2010 | $1,000 | $1,000 |
| 2011 | $1,018 | $978 |
| 2012 | $1,245 | $1,172 |
| 2013 | $1,664 | $1,534 |
| 2014 | $1,900 | $1,726 |
| 2015 | $2,021 | $1,837 |
| 2016 | $2,038 | $1,825 |
| 2017 | $2,201 | $1,928 |
| 2018 | $2,671 | $2,269 |
| 2019 | $3,198 | $2,654 |
| 2020 | $2,914 | $2,381 |
| 2021 | $3,084 | $2,398 |
| 2022 | $4,688 | $3,340 |
| 2023 | $4,063 | $2,788 |
| 2024 | $2,620 | $1,746 |
| 2025 | $2,726 | $1,782 |
| 2026 | $2,915 | $1,905 |
Inflation adjustment uses BLS CPI-U annual data, deflated to 2026 dollars. Nominal stock data from Yahoo Finance (split-adjusted closing prices). Real values are expressed in constant 2010 purchasing-power dollars. For informational and educational purposes only. Not financial advice. Past performance does not guarantee future results. See our methodology and full disclaimer.